Medtronic Inc.'s (MDT) Endeavor drug-coated stent, which launched in the US in February, posted $81 million in US revenue in the company's recently concluded fiscal fourth quarter, Medtronic's top official said Tuesday.
Medtronic Sales Rise 18% Wall Street Journal
Medtronic Beats Analysts' Estimates on Stent Sales (Update2) Bloomberg
